Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
Тип публикации: Journal Article
Дата публикации: 2016-01-12
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 16.918
CiteScore: 109.1
Impact factor: 64.2
ISSN: 00092665, 15206890
PubMed ID:
26756377
General Chemistry
Краткое описание
Compounds Currently in Phase II−III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas Yu Zhou,† Jiang Wang,† Zhanni Gu,† Shuni Wang,† Wei Zhu,† Jose ́ Luis Aceña,*,‡,§ Vadim A. Soloshonok,*,‡,∥ Kunisuke Izawa,* and Hong Liu*,† †Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China ‡Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizab́al 3, 20018 San Sebastiań, Spain Department of Organic Chemistry, Autońoma University of Madrid, Cantoblanco, 28049 Madrid, Spain IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, 48013 Bilbao, Spain Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
50
100
150
200
250
|
|
|
Organic Letters
227 публикаций, 8.48%
|
|
|
Journal of Organic Chemistry
202 публикации, 7.55%
|
|
|
Angewandte Chemie
133 публикации, 4.97%
|
|
|
Angewandte Chemie - International Edition
131 публикация, 4.89%
|
|
|
European Journal of Organic Chemistry
112 публикаций, 4.18%
|
|
|
Advanced Synthesis and Catalysis
110 публикаций, 4.11%
|
|
|
Organic and Biomolecular Chemistry
109 публикаций, 4.07%
|
|
|
Chemical Communications
105 публикаций, 3.92%
|
|
|
Organic Chemistry Frontiers
102 публикации, 3.81%
|
|
|
Chemistry - A European Journal
95 публикаций, 3.55%
|
|
|
Journal of Fluorine Chemistry
92 публикации, 3.44%
|
|
|
ACS Catalysis
55 публикаций, 2.05%
|
|
|
Journal of the American Chemical Society
55 публикаций, 2.05%
|
|
|
Asian Journal of Organic Chemistry
45 публикаций, 1.68%
|
|
|
Chemical Science
44 публикации, 1.64%
|
|
|
Molecules
43 публикации, 1.61%
|
|
|
Synthesis
41 публикация, 1.53%
|
|
|
Tetrahedron Letters
40 публикаций, 1.49%
|
|
|
Beilstein Journal of Organic Chemistry
35 публикаций, 1.31%
|
|
|
Tetrahedron
30 публикаций, 1.12%
|
|
|
ChemistrySelect
29 публикаций, 1.08%
|
|
|
Chinese Journal of Chemistry
27 публикаций, 1.01%
|
|
|
RSC Advances
26 публикаций, 0.97%
|
|
|
Chinese Chemical Letters
24 публикации, 0.9%
|
|
|
Green Chemistry
24 публикации, 0.9%
|
|
|
Chemical Record
21 публикация, 0.78%
|
|
|
Journal of Medicinal Chemistry
20 публикаций, 0.75%
|
|
|
Synlett
20 публикаций, 0.75%
|
|
|
Nature Communications
18 публикаций, 0.67%
|
|
|
50
100
150
200
250
|
Издатели
|
100
200
300
400
500
600
700
800
900
|
|
|
Wiley
808 публикаций, 30.18%
|
|
|
American Chemical Society (ACS)
676 публикаций, 25.25%
|
|
|
Royal Society of Chemistry (RSC)
470 публикаций, 17.56%
|
|
|
Elsevier
335 публикаций, 12.51%
|
|
|
Springer Nature
95 публикаций, 3.55%
|
|
|
MDPI
70 публикаций, 2.61%
|
|
|
Georg Thieme Verlag KG
64 публикации, 2.39%
|
|
|
Beilstein-Institut
35 публикаций, 1.31%
|
|
|
Taylor & Francis
17 публикаций, 0.64%
|
|
|
Pleiades Publishing
16 публикаций, 0.6%
|
|
|
Oxford University Press
10 публикаций, 0.37%
|
|
|
Bentham Science Publishers Ltd.
9 публикаций, 0.34%
|
|
|
Shanghai Institute of Organic Chemistry
9 публикаций, 0.34%
|
|
|
Frontiers Media S.A.
6 публикаций, 0.22%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
6 публикаций, 0.22%
|
|
|
American Association for the Advancement of Science (AAAS)
4 публикации, 0.15%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
3 публикации, 0.11%
|
|
|
openRxiv
3 публикации, 0.11%
|
|
|
Canadian Science Publishing
2 публикации, 0.07%
|
|
|
The Electrochemical Society of Japan
2 публикации, 0.07%
|
|
|
Pharmaceutical Society of Japan
2 публикации, 0.07%
|
|
|
Akademizdatcenter Nauka
2 публикации, 0.07%
|
|
|
The Society of Synthetic Organic Chemistry, Japan
2 публикации, 0.07%
|
|
|
Akademiai Kiado
2 публикации, 0.07%
|
|
|
King Saud University
2 публикации, 0.07%
|
|
|
Cellule MathDoc/Centre Mersenne
2 публикации, 0.07%
|
|
|
Scientific Research Publishing
2 публикации, 0.07%
|
|
|
Science in China Press
2 публикации, 0.07%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 публикация, 0.04%
|
|
|
100
200
300
400
500
600
700
800
900
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
2.7k
Всего цитирований:
2677
Цитирований c 2025:
442
(16.51%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Zhou Yu. et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
ГОСТ со всеми авторами (до 50)
Скопировать
Zhou Yu., Wang J., Gu Z., Wang S., Zhu W., Aceña J. L., Soloshonok V. A., Izawa K., Liu H. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/acs.chemrev.5b00392
UR - https://doi.org/10.1021/acs.chemrev.5b00392
TI - Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
T2 - Chemical Reviews
AU - Zhou, Yu
AU - Wang, Jiang
AU - Gu, Zhanni
AU - Wang, Shuni
AU - Zhu, Wei
AU - Aceña, José Luis
AU - Soloshonok, Vadim A
AU - Izawa, Kunisuke
AU - Liu, Hong
PY - 2016
DA - 2016/01/12
PB - American Chemical Society (ACS)
SP - 422-518
IS - 2
VL - 116
PMID - 26756377
SN - 0009-2665
SN - 1520-6890
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2016_Zhou,
author = {Yu Zhou and Jiang Wang and Zhanni Gu and Shuni Wang and Wei Zhu and José Luis Aceña and Vadim A Soloshonok and Kunisuke Izawa and Hong Liu},
title = {Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.},
journal = {Chemical Reviews},
year = {2016},
volume = {116},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021/acs.chemrev.5b00392},
number = {2},
pages = {422--518},
doi = {10.1021/acs.chemrev.5b00392}
}
Цитировать
MLA
Скопировать
Zhou, Yu., et al. “Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas..” Chemical Reviews, vol. 116, no. 2, Jan. 2016, pp. 422-518. https://doi.org/10.1021/acs.chemrev.5b00392.
Ошибка в публикации?